Analysis of human NSCLC patient datasets demonstrated that GHR expression strongly correlates with pathways linked to fibrosis, apoptosis inhibition, drug metabolizing cytochrome P450 (CYP450) activity, and enhanced invasive potential in NSCLC tumors. The gene discussed is GHR; the disease is non-small cell lung carcinoma.